Starting with the localization of basic IV solutions in 1959, JW Life Science has maintained the No.1 share in Korea’s IV market for more than 60 years—truly a national champion.

We combine unrivaled manufacturing experience in the domestic market with a proven export track record to Europe (EU-GMP) through our global partner Baxter. Building on this foundation, we are expanding into the U.S. market (advancing US FDA cGMP readiness) and growing B2B partnerships worldwide to become a “Global Total Critical Care” company.